Laboratorios Richmond (Argentina) Performance
| RICH Stock | ARS 1,630 35.00 2.10% |
The company secures a Beta (Market Risk) of -0.55, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Laboratorios Richmond are expected to decrease at a much lower rate. During the bear market, Laboratorios Richmond is likely to outperform the market. At this point, Laboratorios Richmond has a negative expected return of -0.0366%. Please make sure to verify Laboratorios Richmond's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Laboratorios Richmond performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Laboratorios Richmond SACIF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Laboratorios Richmond is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 796.9 M | |
| Total Cashflows From Investing Activities | -6 B |
Laboratorios |
Laboratorios Richmond Relative Risk vs. Return Landscape
If you would invest 170,000 in Laboratorios Richmond SACIF on December 27, 2024 and sell it today you would lose (7,000) from holding Laboratorios Richmond SACIF or give up 4.12% of portfolio value over 90 days. Laboratorios Richmond SACIF is generating negative expected returns and assumes 2.6053% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Laboratorios, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Laboratorios Richmond Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratorios Richmond's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratorios Richmond SACIF, and traders can use it to determine the average amount a Laboratorios Richmond's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0141
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RICH |
Estimated Market Risk
| 2.61 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Laboratorios Richmond is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratorios Richmond by adding Laboratorios Richmond to a well-diversified portfolio.
Laboratorios Richmond Fundamentals Growth
Laboratorios Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratorios Richmond, and Laboratorios Richmond fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratorios Stock performance.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.0427 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 21.92 B | |||
| Shares Outstanding | 14.17 M | |||
| Price To Earning | 480.26 X | |||
| Price To Sales | 2.20 X | |||
| Revenue | 16.62 B | |||
| EBITDA | 2.51 B | |||
| Cash And Equivalents | 348.26 M | |||
| Cash Per Share | 4.31 X | |||
| Total Debt | 1.19 B | |||
| Debt To Equity | 39.90 % | |||
| Book Value Per Share | 113.25 X | |||
| Cash Flow From Operations | 3.73 B | |||
| Earnings Per Share | 1.60 X | |||
| Total Asset | 25.69 B | |||
About Laboratorios Richmond Performance
By analyzing Laboratorios Richmond's fundamental ratios, stakeholders can gain valuable insights into Laboratorios Richmond's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratorios Richmond has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratorios Richmond has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Laboratorios Richmond S.A.C.I.F. develops and manufactures pharmaceutical products for physicians, pharmacists, health institutions, and patients in Argentina and internationally. The company was founded in 1935 and is based in Buenos Aires, Argentina. LAB RICHMOND is traded on Buenos-Aires Stock Exchange in Argentina.Things to note about Laboratorios Richmond performance evaluation
Checking the ongoing alerts about Laboratorios Richmond for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratorios Richmond help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratorios Richmond generated a negative expected return over the last 90 days |
- Analyzing Laboratorios Richmond's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratorios Richmond's stock is overvalued or undervalued compared to its peers.
- Examining Laboratorios Richmond's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratorios Richmond's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratorios Richmond's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratorios Richmond's stock. These opinions can provide insight into Laboratorios Richmond's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Richmond's price analysis, check to measure Laboratorios Richmond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Richmond is operating at the current time. Most of Laboratorios Richmond's value examination focuses on studying past and present price action to predict the probability of Laboratorios Richmond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Richmond's price. Additionally, you may evaluate how the addition of Laboratorios Richmond to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |